CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Common Stock [Member]	Common Stock Be Issued [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 70	$ 336,000	$ 42,773,378		$ (45,893,368)	$ (2,783,920)
Beginning balance, shares at Dec. 31, 2020	695,576
Stock issued for conversion of non-redeemable convertible notes	$ 110		3,584,123			3,584,233
Stock issued for conversion of non-redeemable convertible notes, shares	1,092,045
Stock issued for conversion of convertible notes	$ 6		218,121			218,127
Stock issued for conversion of convertible notes, shares	63,672
Stock issued for consulting	$ 4		290,996			291,000
Stock issued for consulting, shares	40,500
Stock issued for officer and director compensation	$ 1		36,349			36,350
Stock issued for officer and director compensation, shares	12,000
Net loss					(4,878,529)	(4,878,529)
Ending balance, value at Jun. 30, 2021	$ 191	336,000	46,902,967		(50,771,897)	(3,532,739)
Ending balance, shares at Jun. 30, 2021	1,903,793
Beginning balance, value at Dec. 31, 2020	$ 70	336,000	42,773,378		(45,893,368)	(2,783,920)
Beginning balance, shares at Dec. 31, 2020	695,576
Ending balance, value at Dec. 31, 2021	$ 600	336,000	58,151,817	4,870	(62,229,405)	(3,736,118)
Ending balance, shares at Dec. 31, 2021	6,000,000
Beginning balance, value at Mar. 31, 2021	$ 125	336,000	45,246,421		(48,784,789)	(3,202,243)
Beginning balance, shares at Mar. 31, 2021	1,245,571
Stock issued for conversion of non-redeemable convertible notes	$ 64		1,619,548			1,619,612
Stock issued for conversion of non-redeemable convertible notes, shares	639,722
Stock issued for consulting	$ 1		20,999			21,000
Stock issued for consulting, shares	10,500
Stock issued for officer and director compensation	$ 1		15,999			16,000
Stock issued for officer and director compensation, shares	8,000
Net loss					(1,987,108)	(1,987,108)
Ending balance, value at Jun. 30, 2021	$ 191	336,000	46,902,967		(50,771,897)	(3,532,739)
Ending balance, shares at Jun. 30, 2021	1,903,793
Beginning balance, value at Dec. 31, 2021	$ 600	336,000	58,151,817	4,870	(62,229,405)	(3,736,118)
Beginning balance, shares at Dec. 31, 2021	6,000,000
Rounding on reverse split	$ 1					1
Rounding on reverse split, shares	5,558
Stock issued for conversion of non-redeemable convertible notes	$ 1,941		2,972,349			2,974,290
Stock issued for conversion of non-redeemable convertible notes, shares	19,410,000
Stock issued for officer and director compensation	$ 9,000		13,491,000			13,500,000
Stock issued for officer and director compensation, shares	90,000,000
Stock issued for the conversion of Series B Stock	$ 400		39,521			39,921
Stock issued for the conversion of Series B Stock, shares	4,000,000
Stock issued for the conversion of Series D Stock	$ 400		39,521			39,921
Stock issued for the conversion of Series D Stock, shares	4,000,000
Deemed dividend - Series A Stock modification			(1,396,721)			(1,396,721)
Deemed contribution - Series B Stock modification			1,354,515			1,354,515
Deemed contribution - Series C Stock modification			834,001			834,001
Deemed contribution - Series D Stock modification			749,085			749,085
Foreign exchange loss				1,701		1,701
Net loss					(17,701,158)	(17,701,158)
Ending balance, value at Jun. 30, 2022	$ 12,342	336,000	76,235,088	6,571	(79,930,563)	(3,340,562)
Ending balance, shares at Jun. 30, 2022	123,415,558
Beginning balance, value at Mar. 31, 2022	$ 702	336,000	58,836,716	3,687	(63,583,002)	(4,405,897)
Beginning balance, shares at Mar. 31, 2022	7,015,558
Stock issued for conversion of non-redeemable convertible notes	$ 1,840		2,287,450			2,289,290
Stock issued for conversion of non-redeemable convertible notes, shares	18,400,000
Stock issued for officer and director compensation	$ 9,000		13,491,000			13,500,000
Stock issued for officer and director compensation, shares	90,000,000
Stock issued for the conversion of Series B Stock	$ 400		39,521			39,921
Stock issued for the conversion of Series B Stock, shares	4,000,000
Stock issued for the conversion of Series D Stock	$ 400		39,521			39,921
Stock issued for the conversion of Series D Stock, shares	4,000,000
Deemed dividend - Series A Stock modification			(1,396,721)			(1,396,721)
Deemed contribution - Series B Stock modification			1,354,515			1,354,515
Deemed contribution - Series C Stock modification			834,001			834,001
Deemed contribution - Series D Stock modification			749,085			749,085
Foreign exchange loss				2,884		2,884
Net loss					(16,347,561)	(16,347,561)
Ending balance, value at Jun. 30, 2022	$ 12,342	$ 336,000	$ 76,235,088	$ 6,571	$ (79,930,563)	$ (3,340,562)
Ending balance, shares at Jun. 30, 2022	123,415,558